GLPwatch
Trials (2036)
Page 20 of 34.
- Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
- WEgovy Real World Assessment of Weight Loss in Korea
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
- A Study of BGM0504 in Participants with Type 2 Diabetes
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
- Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
- Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
- Pharmacogenetics of Response to GLP1R Agonists
- Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- POSE2.0 With GLP-1 Agonist for Obesity Management
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
- A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
- Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
- A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
- Treatment of Diabetic Neuropathy With Liraglutide
- GLP1R-imaging in Post-RYGB Hypoglycemia
- A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
- A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
- Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist
- Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
- Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
- Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
- Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
- Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
- A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
- Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)
- Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes
- A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
- Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
- A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
- Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
- Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
- Tirzepatide vs Liraglutide in Bone
- A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
- Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
- Lifestyle Modification and Liraglutide
- Liraglutide Hospital Discharge Trial
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity
- Prognostic Predictors of Response to Hypoglycemic Therapy
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
- Exenatide for Stress Hyperglycemia
- Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
- Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
- Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
- GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
- Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- Promoting Healthy Children and Youth
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
- Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)